Results 41 to 50 of about 536,624 (300)
Organoids in pediatric cancer research
Organoid technology has revolutionized cancer research, yet its application in pediatric oncology remains limited. Recent advances have enabled the development of pediatric tumor organoids, offering new insights into disease biology, treatment response, and interactions with the tumor microenvironment.
Carla Ríos Arceo, Jarno Drost
wiley +1 more source
The actual states of soil particle transport in and exchange between the Sakiyama and Amitori bays, Iriomote Island, Japan, were investigated using atmosphere–ocean–river observations and numerical simulations.
Shinya Shimokawa +3 more
doaj +1 more source
Population dynamics and size-age structure are analyzed for the chum salmon herd formed in the Prostor and Kurilsky Bays of Iturup Island (Kuril Islands). Release of chum juveniles into the waters of the bays increased from 10.7.106 ind. in 1996 to 197.6.
A. N. Elnikov, O. V. Zelennikov
doaj +1 more source
We have established a humanized orthotopic patient‐derived xenograft (Hu‐oPDX) mouse model of high‐grade serous ovarian cancer (HGSOC) that recapitulates human tumor–immune interactions. Using combined anti‐PD‐L1/anti‐CD73 immunotherapy, we demonstrate the model's improved biological relevance and enhanced translational value for preclinical ...
Luka Tandaric +10 more
wiley +1 more source
Intense Storms Increase the Stability of Tidal Bays
Coastal bays and, specifically, back‐barrier tidal basins host productive ecosystems, coastal communities, and critical infrastructure. As sea level continues to rise and tropical cyclones increase in intensity, these coastal systems are increasingly at ...
K. Castagno +5 more
semanticscholar +1 more source
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska +13 more
wiley +1 more source
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura +19 more
wiley +1 more source
We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober +16 more
wiley +1 more source
Changes in species compositions of fish in the bays of the Northwestern Gulf of Mexico
IntroductionLocal biodiversity is increasing in many temperate and subtropical waters due to climate change. It is often caused by shifting fish distributions, thus the biodiversity gradient, from lower to higher latitudes.
Milton Torres Ceron +3 more
doaj +1 more source
Many patients with urothelial cancer do not benefit from treatment with pembrolizumab, while at risk of severe side effects. Changes in the levels of circulating tumor DNA early during treatment, measured by a simple and affordable assay that can be easily implemented in the clinic, can be used as a prognostic tool to identify these patients.
Youssra Salhi +14 more
wiley +1 more source

